• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Auto-MHC class II-reactive T cell line obtained from MRL mice

Research Project

Project/Area Number 02670162
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Experimental pathology
Research InstitutionKansai Medical University

Principal Investigator

NAGATA Norikazu  Kansai Medical University, 医学部, 講師 (40155940)

Co-Investigator(Kenkyū-buntansha) HISHA Hiroko  Kansai Medical University, 医学部, 助手 (90151422)
TOKI Junko  Kansai Medical University, 医学部, 助手 (40077681)
INABA Muneo  Kansai Medical University, 医学部, 講師 (70115947)
Project Period (FY) 1990 – 1991
Project Status Completed (Fiscal Year 1991)
Budget Amount *help
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 1991: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1990: ¥1,200,000 (Direct Cost: ¥1,200,000)
KeywordsMRL / + mice / lpr mice / lpr-GVHD / Autoreactivity / MHC class II antigen / T cell clone / Autoantibody / Monoclonal antibody / lpr / GVHD / 自己MHC反応性 / T細胞クロ-ン / モノクロ-ナル抗体 / lprーGVHD / Autoreactive T cells / Autoanttdody
Research Abstract

Two congenic strains of MRL mice are knwon; MRL/lpr mice possess lpr gene and MRL/+ mice posses wild type gene. Although they are different at the presence of lpr gene, lethally irradiated MRL/+ mice reconstituted with MRL/lpr bone marrow cells develop severe graft-versus-host disease (GVHD)-like syndrome which is known as lpr-GVHD (1). We have established a CD4^+ T cell line (l/+T1) and examined characteristics of l/+T1 cells in vitro and in vivo.
1. L/+ T1 cells show prliferative response restricted to self-I-E^k molecule in vitro. B cells show relatively high stimulation activity to l/+T1 cells (2).
2. L/+T1 cells can induce proliferation and differentiation of I-E^k B cells, and induce lgM production including autoantibodies (anti-ssDNA antibodies and rheumatoid factors (RF) in vitro (2). 3. Injection of l/+T1 cells to H-2^k mice (MRL/+ and AKR), but not to H-2^d mice, induces enhanced autoreactivity of recipient spleen cells 1 to 2 months after injection. The injection also enhances … More IgG RF prosuction in MRL/+ mice, and slightly IgG and IgM RF production in AKR mice. However, anti-ssDNA antibody production can not be augmented by the injection of l/+ T1 cells, suggesting that autoantibody production is dependent on the presence of antigen (3).
4. When MRL/lpr abnormal T cells were co-cultured with l/+ T1 cells,
abnormal T cells showed a tendency to convert to CD8^+ T cells. However, the conversion was not so marked comparing with control cultures.
5. A hybridoma (25T3, IgM, k) was established from MRL/+ mice immunized with l/+T1 cells. 25T3 monoclonal antibody (mAb) is specific for T cells and reacts with approximately 90% thymocytes. In splenic T cells, approximately 90% CD8^+ cells are positive for 25T3-reactive antigen (25T3-Ag), and CD4^+ T cells are divided to two popualtions by their surface expression of 25T3-Ag; CD4^+25T3-Ag^+ cells relatively correspond to Thl cells and CD4^+25T3^- cel'ls to Th2 cells. 25T3-Ag is approximately 70 kDa by SDS-PAGE. L/+ T1 cells are positive for 25T3-Ag, 25T3 mAb may be useful to analyze autoimmune disease and lpr-GVHD (4). Less

Report

(3 results)
  • 1991 Annual Research Report   Final Research Report Summary
  • 1990 Annual Research Report
  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] N.Nagata,R.Yasumizu,Y.Ohnishi,T.Nakagawa,M.Inaba,and S.Ikehara: "Auto-MHC Class II-reactive T cell reactive T cell line obtained from MRL/+ mice suffering from “lpr-GVHD".I.Characterization of surface phenotypes,specificities and functions in vitro." Immunobiol.181. 367-378 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] T.Nakagawa,N.Nagata,N.Hosaka,M.Inaba,and s.Ikehara: "Analyses of acute graft-versus-host like reaction in[MRL/lpr→MRL/+]chimeric mice using MRL/lpr-Thy-1.1 congenic mice." Cell.Immunol.137. 189-199 (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] N.Nagata,T.Nakagawa,N.Hosaka,and S.Ikehara: "Auto-MHC class II-reactive T cell line obtained from MRL/+ mice suffering from lpr-GVHD.II.Analyses of functional characteristics of T cell line by in vivo administration." Immunobiol.186. 339-350 (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] N.Nagata,S.Taketani,Y.Adachi,N.Hosaka,S.Miyashima,R.Tokunaga,and S.Ikehara: "A monoclonalantiboby reactive with a glycophosphatidylinositol-anchored molecule on T cells defines CD4^+ T cell subsets." Eur.J.Immunol.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 長田 憲和、池原 進: "GVHDと自己免疫病" Medical Immunology. 20. 464-472 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 長田 憲和、池原 進: "免疫毒性と自己免疫" 免疫薬理. 10. 157-161 (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] T. Nakagawa, N. Nagata, N. Hosaka, M. Inaba, and S. Ikehara.: "Analyses of acute graft-versus-host like reaction in [MRL/lpr*MRL/+ chimeric mice using MRL/lpr-Thy-1.1 congenic mice." Cell. Immunol.137. 189-199 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] N. Nagata, R. Yasumizu, Y.Ohnishi, T. Nakagawa, M. Inaba, and S. Ikehara: "Auto-MHC class II-reactive T cell line obtained from MRL/+ mice suffering from "lpr-GVHD". I. Characterization of surface phenotypes, specificities and functions in vitro." Immunobiol.181. 367-378 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] N. Nagata, T. Nakagawa, N. Hosaka, and S. Ikehara: "Auto-MHC class II-reactive T cell line obtained from MRL/+ mice suffering from lpr-GVHD. II. Analyses of functional characteristics of T cell line by in vivo administration." Immunobiol.186. 339-350 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] N. Nagata, S. Taketani, Y. Adachi, N. Hosaka, S. Miyashima, R. Tokunaga, and S. Ikehara: "A monoclonal antibody reactive with a glycophosphatidylinositol-anchored molecule on T cells defines CD4^+ T cell subsets." Eur. J. Immunol.(1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] N.Nagata,R.Yasumizu,Y.Ohnishi,T.Nakagawa,M.Inaba,S.Ikehara: "Auto-MHC class II-reactive T cell line obtained from MRL/+mice suffering from "lpr-GVHD"I.characterization of surface phenotypes,specificities and functions in vitro." Immunobiology. 181. 367-378 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] T.Nakagawa,N.Nagata,N.Hosaka,M.Inaba,R.Yasumizu,R.Ogawa,S.Ikehara: "Analyses of acute graft-versus-host-like reaction in 〔MRL/lpr→MRL/+〕chimeric mice using MRL/lpr-Thy-1.1 congenic mice" Cellular Immunology. 137. 189-199 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] 長田 憲和,池原 進: "GVHDと自己免疫病" Medical Immunology. 20. 464-472 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] 長田 憲和: "自己免疫疾患とGVH病" 免疫薬理. 8. 474-474 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] 長田 憲和,池原 進: "免疫毒性と自己免疫" 免疫薬理. 10. (1992)

    • Related Report
      1991 Annual Research Report
  • [Publications] N.Nagata et al.: "AutoーMHC class IIーreactive T cell line obtained form MRL/+ mice suffering from “lprーGVHD"I.Characterization of surface phenotypes" Immunobiology.

    • Related Report
      1990 Annual Research Report
  • [Publications] 長田 憲和 他: "GVHDと自己免疫病" Medical Immunology.

    • Related Report
      1990 Annual Research Report

URL: 

Published: 1990-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi